If you use a continuous glucose monitoring (CGM) system, you usually have to remove the sensor before any imaging tests like X-rays, CT scans, and MRIs. But now, Abbott’s FreeStyle Libre 2 and 3 ...

In Q1 2024, Abbott's FreeStyle Libre sales grew 25.5% to reach $1.5bn. The Plus version is gradually replacing the older FreeStyle Libre 2 sensor across many markets. England’s NHS, for example ...

Meanwhile, Abbott's FreeStyle Libre and FreeStyle Libre 2 flash CGM systems remain available to patients and listed on the NHS Drug Tariff. The FreeStyle Libre 3 system consists of the sensor ...

Omnipod 5 is now available with both Abbott’s FreeStyle Libre 2 Plus and Dexcom G6 Continuous Glucose Monitoring (CGM) sensor compatibility. Indicated for individuals aged two years and older ...

Omnipod 5 is available with both Abbott’s FreeStyle Libre 2 Plus and Dexcom G6 Continuous Glucose Monitoring (“CGM”) sensor compatibility. The latest development represents a significant ...

Libre Drives Diabetes Care: Abbott’s Diabetes Care business continued to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre.

The Omnipod 5 Automated Insulin Delivery System is now commercially available in Italy, Denmark, Finland, Norway, and Sweden with Abbott’s FreeStyle Libre 2 Plus and Dexcom G6 ACTON, Mass.